Assistant Professor of Pathology, Brigham and Women's Hospital
Pathology
Dr. Michelle S. Hirsch, MD
|
|
Give Review
Michelle Hirsch practices Pathology. She researched medicine at Boston University School of Medicine. Boston University School of Medicine is ranked 30 in research and 52 in primary care medicine Doctor Michelle S. Hirsch, MD is a published doctor and has 58 publications published. The lastest was: 'Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.' She accepts Medicare.
Publications
- GATA3 expression in gestational trophoblastic tissues and tumours.
- Targeted genomic profiling reveals recurrent KRAS mutations and gain of chromosome 1q in mesonephric carcinomas of the female genital tract.
- HNF1β and S100A1 are useful biomarkers for distinguishing renal oncocytoma and chromophobe renal cell carcinoma in FNA and core needle biopsies.
- The Role of Pathology Correlation Approach in Prostate Cancer Index Lesion Detection and Quantitative Analysis with Multiparametric MRI.
- Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma.
- β-Catenin Mutations in Recurrent FIGO IA Grade I Endometrioid Endometrial Cancers.
- FGFR3 expression in primary and metastatic urothelial carcinoma of the bladder.
- Collecting Duct Carcinoma Versus Renal Medullary Carcinoma: An Appeal for Nosologic and Biological Clarity.
- Perivascular epithelioid cell neoplasm (PEComa) of the gynecologic tract: clinicopathologic and immunohistochemical characterization of 16 cases.
- In vivo multiplexed interrogation of amplified genes identifies GAB2 as an ovarian cancer oncogene.
- Transformation of the fallopian tube secretory epithelium leads to high-grade serous ovarian cancer in brca;tp53;pten models.
- Prior appendectomy does not protect against subsequent development of malignant or borderline mucinous ovarian neoplasms.
- Models of Care and NCCN Guideline Adherence in Very-Low-Risk Prostate Cancer.
- FOXO3a loss is a frequent early event in high-grade pelvic serous carcinogenesis.
- Oncogenic mutations in cervical cancer: Genomic differences between adenocarcinomas and squamous cell carcinomas of the cervix.
- Differential expression of p-ERM, a marker of cell polarity, in benign and neoplastic oviductal epithelium.
- PAX8 and PAX5 are differentially expressed in B-cell and T-cell lymphomas.
- Stathmin-1 expression as a complement to p16 helps identify high-grade cervical intraepithelial neoplasia with increased specificity.
- Single nucleotide polymorphisms and risk of recurrence of renal-cell carcinoma: a cohort study.
- BRAF mutations in metanephric adenoma of the kidney.
- Targeted Tumor-Penetrating siRNA Nanocomplexes for Credentialing the Ovarian Cancer Oncogene ID4.
- Multidisciplinary Care and Pursuit of Active Surveillance in Low-Risk Prostate Cancer.
- Pretreatment mitochondrial priming correlates with clinical response to cytotoxic chemotherapy.
- Validation of a TFE3 Break-apart FISH Assay for Xp11.2 Translocation Renal Cell Carcinomas.
- Stathmin 1, a marker of PI3K pathway activation and regulator of microtubule dynamics, is expressed in early pelvic serous carcinomas.
- A comprehensive analysis of PAX8 expression in human epithelial tumors.
- Vascular endothelial growth factor-targeted therapy for the treatment of adult metastatic Xp11.2 translocation renal cell carcinoma.
- Radical retropubic prostatectomy and robotic-assisted laparoscopic prostatectomy: likelihood of positive surgical margin(s).
- High-grade fimbrial-ovarian carcinomas are unified by altered p53, PTEN and PAX2 expression.
- MOLECULAR MARKERS OF EARLY CERVICAL NEOPLASIA.
- Histological 'progression' from low (LSIL) to high (HSIL) squamous intraepithelial lesion is an uncommon event and an indication for quality assurance review.
- Evaluation of vascular space involvement in endometrial adenocarcinomas: laparoscopic vs abdominal hysterectomies.
- A weakly positive human papillomavirus Hybrid Capture II result correlates with a significantly lower risk of cervical intraepithelial neoplasia 2,3 after atypical squ...
- Serous tubal intraepithelial carcinoma: diagnostic reproducibility and its implications.
- A 57-year-old man with abdominal ascites and ventral hernia.
- PAX8 Expression in well-differentiated pancreatic endocrine tumors: correlation with clinicopathologic features and comparison with gastrointestinal and pulmonary carc...
- PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma.
- Prognosis and hormone receptor status in older and younger patients with advanced-stage papillary serous ovarian carcinoma.
- Smoothelin is a specific marker for smooth muscle neoplasms of the gastrointestinal tract.
- A case of adult metastatic Xp11 translocation renal cell carcinoma treated successfully with sunitinib.
- Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria.
- Coexisting intraepithelial serous carcinomas of the endometrium and fallopian tube: frequency and potential significance.
- Embryonic stem cell transcription factors and D2-40 (podoplanin) as diagnostic immunohistochemical markers in ovarian germ cell tumors.
- Increased HLA-DMB expression in the tumor epithelium is associated with increased CTL infiltration and improved prognosis in advanced-stage serous ovarian cancer.
- Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.
- Association of cytokeratin 7 and 19 expression with genomic stability and favorable prognosis in clear cell renal cell cancer.
- Histologic and immunohistochemical decision-making in endometrial adenocarcinoma.
- Pagetoid lesions of the vulva: a collision between malignant melanoma and extramammary Paget disease.
- Atypical genital nevi. A clinicopathologic analysis of 56 cases.
- Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.
- Prospective evaluation of AMACR (P504S) and basal cell markers in the assessment of routine prostate needle biopsy specimens.
- Unresorbed corpora albicantia mimicking a sonographically solid ovarian mass in a postmenopausal woman.
- Thyroid transcription factor-1, but not p53, is helpful in distinguishing moderately differentiated neuroendocrine carcinoma of the larynx from medullary carcinoma of ...
- The role of CD10 staining in distinguishing invasive endometrial adenocarcinoma from adenocarcinoma involving adenomyosis.
- Identical karyotypes in synchronous bilateral clear cell renal cell carcinomas.
- Gauging NOTCH1 Activation in Cancer Using Immunohistochemistry.
- Development of a prosaposin-derived therapeutic cyclic peptide that targets ovarian cancer via the tumor microenvironment.
Schools
Boston University School Of Medicine
BrighamampWomens Hospital
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
Education
-
Brigham and Women's Hospital -
Boston University School of Medicine
Hospital
-
Brigham and Women's Hospital
Helpful Reviews
Similar Doctors
|
|
Dr. Alexander J. McAdam, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Derek H. Oakley, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Amelia E. Huck, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jane B. Cryan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy Kang, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Lindsay B. Hardy, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Julia M. Braza, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Cathatl E. O'Sullivan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adrianne E. Rogers, MD
This Doctor is OpenDoctor Recommended.
|